All Stories

  1. Crystal structure of chorismate mutase from Burkholderia thailandensis
  2. Crystal structure of chorismate mutase fromBurkholderia phymatum
  3. The pathogen-related yeast protein Pry1, a member of the CAP protein superfamily, is a fatty acid-binding protein
  4. Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis
  5. RETRACTED ARTICLE: Summer Research Training Provides Effective Tools for Underrepresented Minorities to Obtain Doctoral Level Degrees
  6. Identification, Characterization, and Structure of Tm16 from Trichuris muris
  7. Structure of SALO
  8. Pry1 CAP domain
  9. Structure of pathogen-related yeast protein, Pry1 in complex with a competitive inhibitor of cholesterol binding
  10. Structural and functional characterization of the CAP domain of pathogen-related yeast 1 (Pry1) protein
  11. Crystal Structure of plasmepsin IV
  12. Expression and purification of an engineered, yeast-expressedLeishmania donovaninucleoside hydrolase with immunogenic properties
  13. Expression, purification, crystallization and crystallographic study ofLutzomyia longipalpisLJL143
  14. Schistosoma mansonivenom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifs. Corrigendum
  15. Structure of ljm19
  16. C- Orthorombic NaGST1
  17. Triclinic NaGST1
  18. Monoclinic NaGST1
  19. Structure of type II dehydroquinase fromPseudomonas aeruginosa
  20. Ibarapa Programme: Half a Century of Rural Health Service, Training, and International Cooperation in Nigeria
  21. Structure of glutathioneS-transferase 1 from the major human hookworm parasiteNecator americanus(Na-GST-1) in complex with glutathione
  22. Structure of Schistosoma mansoni venom allergen-like protein 4 (SmVAL4)
  23. Schistosoma mansonivenom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifs
  24. Crystal Structure of the Type II Dehydroquinase from Pseudomonas aeruginosa
  25. Structural and biochemical analyses of alanine racemase from the multidrug-resistantClostridium difficilestrain 630
  26. alanine racemase [Clostridium difficile 630] complex with cycloserine
  27. Crystal structure of CdALR mutant K 271 T
  28. alanine racemase [Clostridium difficile 630]
  29. Crystal structure of NaASP2 with Zn2+
  30. Crystal structure of 2-Keto-3-deoxy-D-manno-octulosonate-8-phosphate synthase from Pseudomonas aeruginosa.
  31. Structure of 2-keto-3-deoxy-D-manno-octulosonate-8-phosphate synthase fromPseudomonas aeruginosa
  32. Crystal structure of monomeric Na-GST-3, a glutathione s-transferase from the major human hookworm parasite Necator americanus
  33. Structure of monomericNa-GST-3, a glutathioneS-transferase from the major human hookworm parasiteNecator americanus
  34. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones
  35. Nigeria: “Ground Zero" for the High Prevalence Neglected Tropical Diseases
  36. Chicago Sky Blue 6B, A Novel Inhibitor for Macrophage Migration Inhibitory Factor
  37. A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)
  38. Abstract 4746: Structural studies of human glioma pathogenesis-related protein 1(GLIPR1)
  39. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice
  40. crystal structure of sGLIPR1 soaked with zinc chloride
  41. Structure of Human Glioma Pathogenesis-related Protein 1 Reveals Unique loops and surface motifs.
  42. Structural studies of human glioma pathogenesis-related protein 1
  43. Crystal Structure of Na-ASP-1
  44. Co-crystallization studies of full length recombinant BChE with cocaine offers insights into cocaine detoxification
  45. Structure of a two-CAP-domain protein from the human hookworm parasiteNecator americanus
  46. Cocrystallization studies of full-length recombinant butyrylcholinesterase (BChE) with cocaine
  47. Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis
  48. First Crystal Structure of Na-ASP-1, a Two-Domain Cap (Cysteine-Rich Secretory Protein / Antigen 5 / Pathogenesis Related-1) protein
  49. Purification and crystallization of RNase HIII fromStaphylococcus aureus
  50. Crystallization and preliminary X-ray analysis ofNa-ASP-1, a multi-domain pathogenesis-related-1 protein from the human hookworm parasiteNecator americanus. Corrigendum
  51. Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1
  52. Crystallization and preliminary X-ray analysis of Na-SAA-2 from the human hookworm parasiteNecator americanus
  53. Five Tyrosines and Two Serines in Human Albumin Are Labeled by the Organophosphorus Agent FP-Biotin
  54. Crystal structure of recombinant full length human butyrylcholinesterase
  55. Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase
  56. Structure of NaGST-1
  57. Structure of NaGST-2
  58. X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus
  59. Structures of PmSOD1 and PmSOD2, two superoxide dismutases from the protozoan parasitePerkinsus marinus
  60. X-ray structure of PmSOD2, superoxide dismutase from Perkinsus marinus
  61. Crystal structure of Superoxide dismutase from P. Marinus
  62. (33) Structural data on the aging of diethylphosphoryl-butyrylcholinesterase
  63. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials
  64. Crystallization and preliminary X-ray analysis ofNa-ASP-1, a multi-domain pathogenesis-related-1 protein from the human hookworm parasiteNecator americanus
  65. X-ray Structure of Na-ASP-2, a Pathogenesis-related-1 Protein from the Nematode Parasite, Necator americanus, and a Vaccine Antigen for Human Hookworm Infection
  66. Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate
  67. Ethylphosphorylated Butyrylcholinesterase (Aged) Obtained By Reaction With Echothiophate
  68. X-Ray Structure Of Di-Isopropyl-Phosphoro-Fluoridate (Dfp) Inhibited Butyrylcholinesterase after Aging
  69. Novel X-Ray Structure of Na-ASP-2, a PR-1 protein from the nematode parasite Necator americanus and a vaccine antigen for human hookworm infection
  70. Role of Water in Aging of Human Butyrylcholinesterase Inhibited by Echothiophate:  The Crystal Structure Suggests Two Alternative Mechanisms of Aging,
  71. High resolution crystal structures of thymus and activation-regulated chemokine
  72. High resolution crystal structures of thymus and activation-regulated chemokine
  73. Structures of thymus and activation-regulated chemokine (TARC)
  74. Novel Uncomplexed and Complexed Structures of Plasmepsin II, an Aspartic Protease from Plasmodium falciparum
  75. Crystallization and preliminary X-ray studies of thymus and activation-regulated chemokine (TARC)
  76. Structures of Ser205 mutant plasmepsin II fromPlasmodium falciparumat 1.8 Å in complex with the inhibitors rs367 and rs370
  77. STRUCTURE OF PLASMEPSIN II
  78. CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58
  79. CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370
  80. CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367
  81. CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A
  82. CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A
  83. CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A
  84. CRYSTAL STRUCTURES OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE PHOSPHOENOL PYRUVATE
  85. CRYSTAL STRUCTURES OF KDO8P SYNTHASE IN ITS BINARY COMPLEXES WITH THE MECHANISM-BASED INHIBITOR
  86. Crystal Structures of KDOP Synthase in Its Binary Complexes with the Substrate Phosphoenolpyruvate and with a Mechanism-Based Inhibitor,